ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,564.41
      1.08%
      US Tech 100
      19,235.20
      -0.36%
      Dow Jones
      40,415.44
      0.32%
      Brent Oil
      81.945
      0.53%
      Bitcoin
      66,987.42
      -0.91%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Bone Biologics Corporation (BBLG)

      7. Bone Biologics Corporation (BBLG) Financials

      Bone Biologics Corporation

      Bone Biologics Corporation (BBLG)

      NASDAQ
      1.1999
      0.09
      (8.10%)
      Closed July 22 4:00PM
      Delayed by 15 minutes
      1.1999
      0.00
      ( 0.00% )
      Pre Market: 4:00AM
      Delayed by 15 minutes

      Bone Biologics Corporation Financial Summary

      The current BBLG market cap is 1.32M. The company's latest EPS is USD -8.1318 and P/E is -0.15.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -3.15M-3.04M-2.08M-1.16M-903k
      Net Income -3.71M-1.77M-1.92M-1.55M-866k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -2.45M-825k-1.1M-3.67M-9.43M
      Net Income -3.43M-1.83M-1.61M-1.49M-8.95M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 6.78M7.62M4.98M3.74M3.84M
      Total Liabilities 4.01M1.93M1.18M832k165k
      Total Equity 2.77M5.69M3.79M2.91M3.68M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 31k06.68M8.5M3.74M
      Total Liabilities 11.9M13.69M100k2.55M832k
      Total Equity -11.87M-13.69M6.58M5.95M2.91M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -1.35M-4.98M-7.54M-9.56M-1.3M
      Investing N/A N/A N/A N/A N/A
      Financing N/A 4.45M4.45M5.04M1.5M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -3.25M-427k-1.23M-3.57M-9.56M
      Investing N/A N/A N/A N/A N/A
      Financing 2.32M403k7.9M4.43M5.04M

      Stats and Ratios

      Market Cap 1.32M
      Price to Earnings Ratio -0.15
      Price to Sales Ratio 0
      Price to Cash Ratio 0.44
      Price to Book Ratio 0.45
      Dividend Yield -

      Share Statistics

      Shares Outstanding 1.1M
      Average Volume (1 week) 21.41k
      Average Volume (1 Month) 57.34k
      52 Week Change -89.51%
      52 Week High 12.2392
      52 Week Low 1.00
      Spread (Intraday) 0.2 (16.53%)

      Company Info

      Company Name Bone Biologics Corporation
      Address 1013 centre road
      wilmington, delaware 19805
      Website https://www.bonebiologics.com
      Industry ortho,prosth,surg appl,suply (3842)